How much funding has Flatiron raised?

Flatiron has raised $313.0M in total funding, most recently a Series C round.

Who are Flatiron's investors?

Flatiron's investors include GV, Roche, First Round Capital, Allen & Company, Baillie Gifford, Labcorp.

Where is Flatiron headquartered?

Flatiron is headquartered in New York, New York, United States.

What industry is Flatiron in?

Flatiron operates in Healthcare.

Flatiron

Oncology, answered.

New York, United States · Founded 2012 · $313.0M raised

Healthcare

Headquarters: New York, New York
Founded: 2012
Business Model: B2B

Total Funding: $313.0M
Last Round: $175.0M Series CJan 2016
Rounds: 3

About

Flatiron Health combines AI-powered technology, deep clinical expertise, and real-world oncology data to help providers and life science organizations navigate cancer care and research with greater clarity and speed. Founded in 2012, the company operates a global oncology engine built on one of the world's largest oncology datasets spanning the US, UK, Germany, and Japan, alongside point-of-care technology used by community oncologists across the US. Since becoming an independent affiliate of the Roche Group in 2018, Flatiron has expanded its reach across the oncology ecosystem, with its real-world data informing over 2,000 scientific publications.

Summary

Flatiron is a Healthcare company based in New York, United States, founded in 2012. It has raised $313.0M in total across 3 rounds, most recently a $175.0M Series C round in Jan 2016. Investors include GV, Roche and First Round Capital.